Cargando…
Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
There has been increasing interest in finding non-invasive biomarkers for neurodegenerative diseases such as Alzheimer’s disease (AD). This observational study investigated AD-specific biomarkers in tear fluid. Tear fluid was collected from a total of 65 subjects, including 23 patients with subjecti...
Autores principales: | Gijs, Marlies, Ramakers, Inez H. G. B., Visser, Pieter Jelle, Verhey, Frans R. J., van de Waarenburg, Marjo P. H., Schalkwijk, Casper G., Nuijts, Rudy M. M. A., Webers, Carroll A. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608861/ https://www.ncbi.nlm.nih.gov/pubmed/34811435 http://dx.doi.org/10.1038/s41598-021-01993-x |
Ejemplares similares
-
Tear biomarkers for Alzheimer’s disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study
por: van de Sande, Nienke, et al.
Publicado: (2023) -
Pre-analytical sample handling effects on tear fluid protein levels
por: Gijs, Marlies, et al.
Publicado: (2023) -
In-Depth Investigation of Conjunctival Swabs and Tear Fluid of Symptomatic COVID-19 Patients, an Observational Cohort Study
por: Gijs, Marlies, et al.
Publicado: (2021) -
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2017) -
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2018)